Literature DB >> 9677367

A novel phospholipase A2 inhibitor with leucine-rich repeats from the blood plasma of Agkistrodon blomhoffii siniticus. Sequence homologies with human leucine-rich alpha2-glycoprotein.

K Okumura1, N Ohkura, S Inoue, K Ikeda, K Hayashi.   

Abstract

The phospholipase A2 (PLA2) inhibitor PLIbeta, purified from the blood plasma of Chinese mamushi snake (Agkistrodon blomhoffii siniticus), is a 160-kDa trimer with three 50-kDa subunits; and it inhibits specifically the enzymatic activity of the basic PLA2 from its own venom (Ohkura, N., Okuhara, H., Inoue, S., Ikeda, K., and Hayashi, K. (1997) Biochem. J. 325, 527-531). In the present study, the 50-kDa subunit was found to be glycosylated with N-linked carbohydrate, and enzymatic deglycosylation decreased the molecular mass of the 50-kDa subunit to 39-kDa. One 160-kDa trimer of PLIbeta was found to form a stable complex with three basic PLA2 molecules, indicating that one basic PLA2 molecule would bind stoichiometrically to one subunit of PLIbeta. A cDNA encoding PLIbeta was isolated from a Chinese mamushi liver cDNA library by use of a probe prepared by a polymerase chain reaction on the basis of the partially determined amino acid sequence of the subunit. The cDNA contained an open reading frame encoding a 23-residue signal sequence followed by a 308-residue protein, which contained the sequences of all the peptides derived by lysyl endopeptidase digestion of the subunit. The molecular mass of the mature protein was calculated to be 34,594 Da, and the deduced amino acid sequence contained four potential N-glycosylation sites. The sequence of PLIbeta showed no significant homology with that of the known PLA2 inhibitors. But, interestingly, it exhibited 33% identity with that of human leucine-rich alpha2-glycoprotein, a serum protein of unknown function. The most striking feature of the sequence is that it contained nine leucine-rich repeats (LRRs), each of 24 amino acid residues and thus encompassing over two-thirds of the molecule. LRRs in PLIbeta might be responsible for the specific binding to basic PLA2, since LRRs are considered as the motifs involved in protein-protein interactions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9677367     DOI: 10.1074/jbc.273.31.19469

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Purification and inhibitory profile of phospholipase A2 inhibitors from Australian elapid sera.

Authors:  P G Hains; K W Broady
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  Autologous extracellular cytochrome c is an endogenous ligand for leucine-rich alpha2-glycoprotein and beta-type phospholipase A2 inhibitor.

Authors:  Ryoichi Shirai; Rikiya Gotou; Fumiyasu Hirano; Kiyoshi Ikeda; Seiji Inoue
Journal:  J Biol Chem       Date:  2010-05-04       Impact factor: 5.157

3.  Purification, characterization and cDNA cloning of a phospholipase A2 inhibitor from the serum of the non-venomous snake Elaphe quadrivirgata.

Authors:  K Okumura; K Masui; S Inoue; K Ikeda; K Hayashi
Journal:  Biochem J       Date:  1999-07-01       Impact factor: 3.857

4.  Two phospholipase A2 inhibitors from the plasma of Cerrophidion (Bothrops) godmani which selectively inhibit two different group-II phospholipase A2 myotoxins from its own venom: isolation, molecular cloning and biological properties.

Authors:  S Lizano; Y Angulo; B Lomonte; J W Fox; G Lambeau; M Lazdunski; J M Gutiérrez
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

5.  Therapeutic application of natural inhibitors against snake venom phospholipase A(2).

Authors:  Ramar Perumal Samy; Ponnampalam Gopalakrishnakone; Vincent Tk Chow
Journal:  Bioinformation       Date:  2012-01-06

6.  Biomarkers of systemic inflammation in farmers with musculoskeletal disorders; a plasma proteomic study.

Authors:  Bijar Ghafouri; Anders Carlsson; Sara Holmberg; Anders Thelin; Christer Tagesson
Journal:  BMC Musculoskelet Disord       Date:  2016-05-10       Impact factor: 2.362

Review 7.  Endogenous phospholipase A2 inhibitors in snakes: a brief overview.

Authors:  Patrícia Cota Campos; Lutiana Amaral de Melo; Gabriel Latorre Fortes Dias; Consuelo Latorre Fortes-Dias
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2016-12-21

Review 8.  Alpha-type phospholipase A2 inhibitors from snake blood.

Authors:  Norival A Santos-Filho; Claudia T Santos
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-03-23

9.  Identification, description and structural analysis of beta phospholipase A2 inhibitors (sbβPLIs) from Latin American pit vipers indicate a binding site region for basic snake venom phospholipases A2.

Authors:  Consuelo Latorre Fortes-Dias; Carlos Alexandre H Fernandes; Paula Ladeira Ortolani; Patrícia Cota Campos; L A Melo; Liza Figueiredo Felicori; Marcos Roberto M Fontes
Journal:  Toxicon X       Date:  2019-02-26

10.  Up-regulation of the expression of leucine-rich alpha(2)-glycoprotein in hepatocytes by the mediators of acute-phase response.

Authors:  Ryoichi Shirai; Fumiyasu Hirano; Naoki Ohkura; Kiyoshi Ikeda; Seiji Inoue
Journal:  Biochem Biophys Res Commun       Date:  2009-03-24       Impact factor: 3.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.